Alembic Pharmaceuticals Limited has submitted a regulatory disclosure to both BSE Limited and National Stock Exchange of India Ltd regarding scheduled investor meetings. Company officials will conduct one-on-one meetings with institutional investors and analysts in Mumbai on Wednesday, 23rd September, 2026. The meetings are scheduled to commence at 10:00 AM onwards.
The company has noted that meeting schedules may be subject to change due to exigencies on the part of either the investors/analysts or the company itself. All discussions during these meetings will be based exclusively on publicly available information, with the company explicitly stating that no Unpublished Price Sensitive Information (UPSI) shall be shared during these interactions.